Horanlli, Endri External Entity

Publications

Sort by

Selected publications

  • Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-Hodgkin lymphoma.  Clinical cancer research : an official journal of the American Association for Cancer Research2011 Academic Article GET IT
    Times cited: 18

Other